Edition:
United Kingdom

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

14.21USD
4:57pm GMT
Change (% chg)

$0.14 (+1.00%)
Prev Close
$14.07
Open
$14.11
Day's High
$14.52
Day's Low
$13.96
Volume
11,296
Avg. Vol
89,847
52-wk High
$26.74
52-wk Low
$11.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.40 December 23 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.25 1.25 1.25 1.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 4.70 9.40 0.00 --
Quarter Ending Jun-18 2 5.30 10.60 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 2 -0.40 -0.35 -0.45 --
Quarter Ending Jun-18 2 -0.51 -0.50 -0.53 --
Year Ending Dec-18 4 -1.93 -1.70 -2.19 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 9.30 0.00 9.30 100.00
Quarter Ending Jun-17 3.10 0.00 3.10 100.00
Earnings (per share)
Quarter Ending Sep-17 -0.41 -0.56 0.15 -36.59
Quarter Ending Jun-17 -0.53 -9.30 8.77 -1,643.86

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 4.70 4.70 9.40 9.40 --
Quarter Ending Jun-18 5.30 5.30 10.60 10.60 --
Year Ending Dec-18 0.00 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 -0.40 -0.40 -0.42 -0.45 --
Quarter Ending Jun-18 -0.51 -0.51 -0.50 -0.50 --
Year Ending Dec-18 -1.93 -1.93 -1.89 -1.72 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Mar-18 0 0 1 0
Quarter Ending Jun-18 0 0 0 1
Year Ending Dec-18 0 0 0 1